Sacubitril/valsartan for heart failure in adults with complex congenital heart disease

Heart failure is an important cause of morbidity and mortality in adults with congenital heart disease (ACHD). Sacubitril/valsartan is an established treatment for heart failure with reduced ejection fraction due to acquired cardiovascular disease. Data in adults with complex congenital heart disease (CHD) is lacking.
Source: International Journal of Cardiology - Category: Cardiology Authors: Source Type: research